GRAPHICAL USER INTERFACE FOR COVID-19 DIAGNOSIS: LEVERAGING DEEP LEARNING
Main Article Content
Abstract
Tens of thousands of people have died as a result of the COVID-19 epidemic, which has shut down transport and plunged the world into an unprecedented state of turmoil. COVID-19 still presents a significant risk to public health. This article claims that AI can be used to combat the virus. Generative Adversarial Networks (GANs) have been demonstrated to be effective for this goal (GAN). Using an integrated bioinformatics approach, these systems facilitate the easy access to data from a variety of sources, both organised and unstructured, for medical professionals and researchers. Technologies utilising artificial intelligence (AI) can expedite COVID-19 diagnosis and treatment. In order to choose inputs and targets for an Artificial Neural Network-based tool for COVID-19 challenges, a large number of medical reports were evaluated. Furthermore, a variety of data types, including clinical data and medical imaging, are inputs into this platform that can improve the performance of the introduced technique and lead to optimal outcomes in real-world applications.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
References
C. Huang et al., “Clinical features of patients infected with 2019 novel corona virus in Wuhan, China,” The lancet, vol. 395, no. 10223, pp.497-506, 2020.
N.Chenetal.,“Epidemiologicalandclinicalcharacteristicsof99casesof 2019novelcoronaviruspneumonia in Wuhan, China :a descriptive study,” The Lancet, vol. 395, no. 10223, pp. 507-513, 2020.
D. Wang et al., “Clinical characteristics of138 hospitalized patients with 2019novelcoronavirus–infectedpneumoniainWuhan, China,”Jama,vol.323, no. 11, pp. 1061-1069, 2020.
K.Liuetal.,“Clinicalcharacteristicsofnovelcoronaviruscasesintertiary hospitals in Hubei Province,” Chinese medical journal, 2020.
T. Guo et al., “Cardiovascular implications of fatal outcomes of patients with corona virus disease 2019 (COVID-19),” JAMA cardiology, 2020.
P. Hemet and J. Tremblay, “Artificial intelligence in medicine, “Metabolism, vol. 69, pp. S36-S40, 2017